81
Participants
Start Date
November 13, 2024
Primary Completion Date
January 28, 2026
Study Completion Date
April 21, 2026
REGN7544
Subcutaneous (SC) administration
Placebo
SC administration
RECRUITING
New York University Langone, New York
RECRUITING
Columbia University, New York
RECRUITING
Innovative Research of West Florida, Inc., Clearwater
RECRUITING
Vanderbilt University Medical Center, Nashville
RECRUITING
Indiana University Health Neuroscience Center, Indianapolis
RECRUITING
Mayo Clinic, Rochester
RECRUITING
Saint Luke's MidAmerica Heart Institute, Kansas City
RECRUITING
University of Oklahoma Health Sciences Center, Oklahoma City
RECRUITING
University of Texas Southwestern, Dallas
RECRUITING
University of Utah, Salt Lake City
RECRUITING
Mercy Gilbert Medical Center, Gilbert
RECRUITING
Southern California Heart Specialists, Pasadena
RECRUITING
North County Neurology Associates, Carlsbad
RECRUITING
Stanford University, Palo Alto
RECRUITING
Yale University, New Haven
RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
University of Calgary, Calgary
RECRUITING
University of Alberta Hospital, Edmonton
Regeneron Pharmaceuticals
INDUSTRY